There is growing public concern about the possible health risks, particularly increased cancer risks of exposure to magnetic fields (MF) associated with power distribution systems. Recently, we have started a series of animal studies to investigate this issue, using the DMBA (7,12-dimethylbenz[a]anthracene) model of breast cancer in female rats. In the present study, female rats were chronically exposed to a 50-Hz, 50 jlTesla (uT) MF with or without DMBA treatment Because alterations in circulating levels of the pineal hormone melatonin and impaired immune system functions have been involved in breast cancer growth, and both melatonin and immune system are thought to be targets for MF-effects, serum melatonin and the proUferative capacity of splenic lymphocytes were determined in MF-exposed and sham-exposed rats. For this purpose, 216 female Sprague-Dawley rats were divided into four groups. Two of the groups (with 99 animals each) received oral applications of DMBA and were either shamexposed or exposed in a 50-Hz, 50 uT MF for 24 h/day 7 days/week for a period of 91 days. The other two groups (9 animals each) were either sham-exposed or MF-exposed without DMBA treatment. The exposure chambers and all other environmental factors were identical for MF-exposed and sham-exposed animals. The DMBA-treated animals were palpated once weekly to assess the development of mammary tumors. At the end of the three-month period of MF exposure, the number and size of mammary tumors was determined by autopsy. In controls, DMBA induced tumors in -55% of the animals within the 3 month period of sham-exposure. Already 8 weeks after DMBA application, the MF-exposed group exhibited significantly more tumors than sham-exposed animals. At time of autopsy, significantly more MF-exposed DMBA-treated rats exhibited macroscopically visible mammary tumors than DMBAtreated controls, thus indicating that MF exposure enhances the development and growth of cancers in this model. Comparison of the data from 50 |iT with recent data from other flux densities indicated that long-term MF exposure of DMBA-treated rats increases the incidence of palpable and/or macroscopically visible mammary tumors in a highly dose-related fashion. Determination of nocturnal serum melatonin after 9 and 12 weeks of exposure at 50 \iT did not yield significant differences between MF-exposed rats and sham-exposed controls, whereas a marked suppression of T cell proliferative capacity was seen in MF exposed
Introduction
The question whether weak, extremely low-frequency (50/60-Hz) magnetic fields (MFs*) as produced by power lines and household appliances can initiate and/or promote carcinogenesis or could be involved in the progression of cancer is a matter of ongoing debate. Laboratory studies on MF-effects to determine whether there is a plausible biological link between MF exposure and increased cancer risk have been recently criticized because of shortcomings in control experiments and/or lack of independent replication of reported responses (1-3). Criticisms were based on in vitro cellular studies, particularly on MF-effects on gene transcription (1-3). However, there is accumulating laboratory evidence from in vivo studies suggesting that, rather than gene transcription, the pineal hormone melatonin may be a plausible biological link between MF exposure and carcinogenesis (4) .
It is long known that weak, static MFs induce pineal metabolic and physiologic changes (5) , with the retinas considered as the site of magnetoreception (6) , and there is now general agreement that reduced pineal melatonin synthesis is a consequence of MF exposure under certain conditions (6) . More recently, it was demonstrated that exposure of rats to 50-Hz MFs of low ^Tesla (pT) flux density led to a drop in night-time levels of both pineal and serum melatonin (7, 8) . Reduction of melatonin levels by pinealectomy or constant light has been shown to accelerate neoplastic growth in the 7,12-dimethylbenz[a]anthracene (DMBA) rat model of breast cancer, most possibly because of reduced inhibition by melatonin of prolactin and estrogen secretion (9) . It was thus tempting to examine if MF exposure also accelerates breast cancer growth in rat models of chemical carcinogenesis.
The first laboratory evidence for a link between MF exposure and breast cancer growth came from a study of Beniashvili et al. (10) , indicating that chronic exposure of female rats to static and 50-Hz MF in the uT range increased the growth and progression of NMU (nitrosomethylurea) induced mammary tumors. Similar to the observations of Beniashvili et al. (10) in the NMU model, we reported that chronic exposure of DMBA-treated female rats to a 50-Hz, 100 ^T MF significantly enhanced tumor growth and the incidence of malignancies compared to sham-exposed controls (11, 12) , thus indicating that MF-effects on mammary carcinogenesis can be replicated in different laboratories.
The finding of significantly enhanced neoplastic growth and progression seen at a MF of 100 uT prompted us to undertake an extensive series of experiments to study whether the effect of 50-Hz MF exposure is correlated to the dose, i.e. flux \LMevissen et al. density used. In contrast to the findings with 100 (iT (11, 12) , exposure of female rats at 0.3-1 (J.T did not cause any significant alteration in DMBA-induced breast cancer development and growth (8) . In a subsequent study on 10 (XT, a tendency to enhanced growth of DMBA-induced mammary tumors was seen, but again the difference to concurrent sham controls was not significant (13) . In the present study, we chose a flux density of 50 (iT for chronic exposure of DMBA-treated female rats, using the same experimental protocol as in the previous experiments. In addition to breast cancer development and growth, we determined nocturnal melatonin levels in serum after 9 and 12 weeks of MF exposure to examine if melatonin synthesis was depressed under the conditions of this study. Furthermore, in view of accumulating evidence implicating impairment of immune surveillance in MF-effects on carcinogenesis (4,14-17), we determined if the proliferative capacity of T cells is altered in MF exposed rats.
Materials and methods

Animals
Female Sprague-Dawley outbred rats, 42 days old, were obtained from the Institute of Laboratory Breeding (Hagemann, Extertal, Germany) and were acclimatized for 10 days in one of the animal rooms in the Department of Pharmacology before being used for the MF experiment.
Magnetic field exposure
With respect to the protocol for MF exposure, we tried to follow the protocol outline of the National Toxicology Program of the National Institute of Environmental Health Sciences of the National Institutes of Health (Research Triangle Park, NC) for prechronic toxicity evaluation of alternating MF as closely as possible.
The exposure system, which was built by the Department of High Voltage Engineering (Technical University, Braunschweig, Germany), consisted of six identical exposure chambers, each with four square coils. The arrangement of the coils strictly followed the instructions of Merritt et al. (18) with 26 turns on the outer coils and 11 turns on the inner coils as described recently (12, 13) . The length of the sides of the coils was 1 m. The gauge of the copper-wire was 1.5 mm 2 . The exposure chambers were made of Trovidur, which is a special hard, PVC. The exposure chambers were placed on wooden posts to avoid vibration. Separate wooden posts were used for the cages inside the coils so that the animal cages were not connected to the same mounting as the exposure chambers. The temperature inside the cages was not altered by the negligible heating produced by the current flow in the coils. At 50 |iT, the coils produced < 1.0 W. No difference between exposure and sham coils regarding noise, vibration, temperature or light was evident.
Each exposure chamber had place for four cages (two levels with two cages each) with 9-10 animals per cage (see below). Three of the exposure chambers were energized from a standard 220 V outlet and a step-down transformer providing the necessary voltage of 4 V. The other three exposure chambers were used with absent MF for sham-control. The room with the exposure chambers had dimensions of 7.32 mX4.52 m. The three energized exposure chambers stood side by side on one side of the room, whereas the three sham (control) exposure chambers stood at the other side with a distance of ~5 m between energized chambers and controls. The current in the wires of the exposure coils was 1.07 A, which resulted in a horizontally-polarized magnetic 50-Hz-field with a flux density of 50 nT (i.e. 500 mGauss) r.m.s. The nonenergized exposure coils used for sham-exposure received a stray MF field from the energized coils which was calculated to be -0.05 )iT in the volume of the sham exposure chambers, which was subsequently verified by MF measurements. Measurements of the 50-Hz MF field over the volume of the sham exposure chambers yielded values of 0.03-0.04 (iT when the MF coils were not energized, i.e. due to the ambient 50-Hz MF field in the laboratory, which was recorded over a 24-h period with all coils turned off. The static earth MF was measured with a Bell 610 Gaussmeter, The component parallel to the exposure field was 16 \xT, and the component perpendicular to the exposure field was 36 |iT so that the generated 50-Hz field was horizontal and parallel to the horizontal component of the earth's North/South MF. The electric field in the exposure chambers was measured with an EMDEXC instrument together with a MI15EB handle (Electric Field Measurements, W. Stockbridge, MA); ambient values varied from 17-58 V/m and were not significantly increased when the exposure chambers were energized.
Treatment of animals and MF exposure
The rats were randomly divided into four groups: (a) a group of 99 rats for DMBA treatment and MF exposure; (b) a group of 99 rats for DMBA treatment and sham-exposure (DMBA control); (c) a group of 9 rats with MF exposure but no DMBA; (d) a group of 9 rats with sham-exposure but no DMBA. Additional groups of animals were used for measurement of ornithine decarboxylase (ODC) as described recently (19); data from these groups will not be included in the present study. At the onset of the MF experiment, at which the rats were 52 days of age. the groups were brought into the room with the exposure chambers. Each rat of groups a and b received an oral administration (by gastric intubation) of 5 mg DMBA dissolved in sesame oil (1 ml/rat), was then placed in its home cage into the exposure chamber and MF exposure (flux density 50 nT; frequency = 50-Hz) was started for 24 h/day 7 days per week except for the sham controls, which were placed in identical exposure chambers without MF. Rats from groups c and d were placed into the exposure chambers (with or without MF) without DMBA treatment, but vehicle (sesame oil) was orally administered instead. Rats were housed 9-10 per cage within the exposure chambers; the 39 cmX55 cmX 22 cm cages were made of acrylic as were the feeding dishes, water bottles and cage lids. The rats were housed under controlled conditions of temperature (23-24°C), humidity (-50%) and light (12-h dark/light cycle; light off at 5 p.m.); food (Altromin standard rat diet) and water were available ad libitum. Light intensity produced by the artificial white light in the room with the exposure system varied between 16 and 35 lux (measured by a luxmeter in the exposure chambers). In the dark period, the room was weakly illuminated by dim red light (using two Phillips 15 W dark-room lamps) which led to a light intensity of -0.1 lux (measured in the exposure chambers). In this respect, it is important to note that dim red light exposure at night, which itself does not inhibit pineal melatonin producuon, seems to be a necessary predisposing factor for MF to inhibit the melatonin-forming ability of the mammalian pineal gland (20,21).
Animals were weighed once per week; cage cleaning was done three times a week; cage rotation in the exposure chambers was done once a week. Following the initial application of DMBA in groups a and b, oral treatment with DMBA (5 mg) was repeated at weekly intervals up to a total of four applications per animal. Previous studies have shown that DMBA induces mammary tumors in -40-60% of animals within 3 months when administered in this way (8, 12, 13) . This study design with repeated DMBA application under MF exposure allows the evaluation of the enhancing effects of a chosen field on mammary carcinogenesis, including MF-effects at the time of initiation. Groups c and d received repeated applications of vehicle instead of DMBA. Each week following the last DMBA or vehicle application, the animals were palpated to assess the development of tumors. The size of palpable tumors was estimated by a rating scale as recently described (11) . The 50-Hz MF was measured once per week by a person not involved in the animal experimentation. Thus, all persons involved in handling, palpation and subsequent necropsy and pathological examination of rats were not aware which groups of rats were MF-exposed or sham-exposed, i.e. the study was done 'blind'. Furthermore, the persons involved in melatonin determinations and T cell experiments performed all measurements in a blind fashion.
Melatonin determination
After 9 weeks of exposure, blood was sampled by orbital puncture from 16 MF-exposed and 16 sham-exposed rats between 10.30-11.00 p.m., i.e. 5.5-6.0 h after onset of the dark phase, under the dim red light. The basis for selecting the time of taking the samples were preliminary experiments with repeated blood sampling showing that the nocturnal melatonin peak occurred at this time in this strain of rats (Mevissen and Loscher, unpublished data). Since our hypothesis was that MF exposure enhances tumor growth by reducing nocturnal melatonin, only rats treated with DMBA and showing palpable mammary tumors were used for melatonin determination. Blood from the DMBA treated rats was centnfuged and serum was stored at -80°C until melatonin assay. Serum melatonin was determined in a single-blind fashion by radioimmunoassay as described previously (22) . The experiment was repeated after 12 weeks of exposure, using 16 other MF-exposed and sham-exposed rats, respectively.
Autopsy
After 91 days of MF exposure or sham-exposure, all rats were anaesthetized with ether and sacrificed by cervical dislocation. For evaluation of mammary tumors, the skin was opened by a midline incision to expose the six pairs of mammary glands extending from the salivary glands to the perianal region. The size of macroscopically visible mammary tumors was measured using a calliper after dissection, and tumor volume was calculated from the length, width and depth of tumors taking an ellipsoid as a basis. Tumors (usually large tumors) which had been gnawed at by the animals were not included in size measurements (15 tumors in the MF-exposed group and five tumors in the sham-exposed group). Small tumors were fixed in 4% phosphate-buffered formalin (pH 7.3), embedded in Paraplast, sectioned and stained with haematoxylin and eosin, and examined histologically to confirm the diagnosis. We did not perform a complete histopathological evaluation of all mammary lesions since previous studies of our group have shown that almost all tumors induced by DMBA at the dose and time schedule chosen for the present experiments are adenocarcinomas (8, 12) . Furthermore, these previous studies showed that MF exposure (at 100 p.T) does not increase the incidence of DMBAinduced lesions, but increases tumor growth, which can be demonstrated by measurement of number and size of macroscopically visible tumors (12) .
Some of the DMBA-treated rats had to be dissected prior to the end of the 91-days exposure period. Of the 99 DMBA-treated rats used per group, two of the MF-exposed rats died before the 91 days of MF-or sham-exposure. Furthermore, four of the MF-exposed and two of the sham-exposed rats with DMBA had to be sacrificed before 91 days of exposure because of marked weight loss, in part associated with vaginal bleeding. Rats which died or were sacrificed before the end of the 91-day exposure period were included in the pathological examination. The weight of liver and spleen was recorded in all animals.
7" cell activation
A total of 36 rats (i.e. 9 rats per group) were used for this part of the study. Methods of lymphocyte preparation and stimulation by the T cell-selective mitogen concanavalin A (Con A) have been described in detail previously (23) . In short, after sacrifice of animals at time of autopsy, i.e. following 91 days of MF exposure or sham-exposure, the spleen was immediately removed and was placed into ice-cold sterile tissue culture medium (RPMI 1640, supplemented with L-glutamine; (Life Technologies; Eggenstein, Germany). The fibrous capsule was removed, the spleen was cut into small pieces, and mazerated by a glass Potter-Elvehjem homogenizer to release lymphocytes. Tissue remnants were removed by filtering cells through nylon wool. The cell suspension was centrifuged at 600 g for 10 min, and the residue was resuspended in 2 ml RPMI 1640. The number of viable cells was determined by a counting chamber in dilutions of this cell suspension, using the trypan blue exclusion test. Using a dilution with 2-4X10* cells/ml, lymphocytes were then cultured in RPMI 1640 supplemented with 10% fetal calf serum (Boehringer-Mannheim, Germany) in 96-well microtiter plates in a total volume of 0.2 ml of RPMI 1640 (supplemented with penicillin/streptomycin) either with or without adding 1 |ig Con A (which resulted in optimal stimulation [23] ). Per spleen, four samples were cultured with and 4 samples without Con A (Biochrom; Berlin, Germany). After 50 h at 37°C with 5% CO 2 , I |iCi of [ 3 H]thymidine was added (specific activity 5 Ci/mmol; Amersham; Braunschweig, Germany), and the cells were further incubated for 2 h. Lymphocytes were then harvested with an automatic cell harvester (Scatron; Flow Laboratories) on glass fiber filters. Radioactivity was measured in scintillation cocktajl by liquid scintillation counting. Samples which did not show a clear response to Con A (i.e. no stimulated proliferation) were omitted from further evaluation.
Statistical evaluation
All observations were tested for normality using the Kolmogorov-Smirnov test, and subsequent statistical comparisons were either done by parametric or non-parametric tests. Differences between groups in tumor incidence at specific weeks of tumor development were determined using the chi-square test and in the mean number and size of tumors by the Mann-Whitney U-test. Volume of tumors was calculated as median with range from the first to the third quartile (interquartile range); differences were calculated by the U-test. The cumulative proportions of animals with tumors (incidence curves) were calculated by the product-limit method where animals which died or were sacrificed without tumors were included as censorized, and the difference between groups was tested for statistical significance by product-limit-survival analysis. The mean numbers of viable splenic lymphocytes were compared by analysis of variance (ANOVA). T cell activation data (calculated as median with interquartile range) were statistically evaluated by ANOVA on ranks (Kruskal-Wallis test), followed by U-test for posthoc analysis. Student's Mest was used to calculate statistical significance of differences between melatonin serum levels. All calculations were done by the SAS and BMDP programmes. Since our initial hypothesis was that MF exposure would enhance tumor development and growth, all statistical tests on tumor data were used as onesided tests.
Results
Effects of MF exposure on breast cancer formation
The cumulative proportion of DMBA-treated animals which developed mammary tumors during the period of MF-or . In addition to the data from palpation (weeks 5-13), the percentage of rats with macroscopically visible tumors at autopsy is shown. The P value refers to the statistical evaluation of data from the palpation period by the product-limit method, indicating that the two incidence curves differ significantly. Stars indicate individual differences (P at least < 0.05) between MF-exposed and sham-exposed groups. sham-exposure is shown in Figure 1 . The first mammary tumors could be palpated in both groups at 6-7 weeks following the initial DMBA application. The MF-exposed group tended to exhibit a higher tumor incidence than sham-exposed rats throughout the period of exposure, which was significant at 8 and 9 weeks of exposure. At the end of the exposure period, 55 MF-exposed and 51 sham-exposed rats of the 99 animals per group had developed palpable tumors. Statistical evaluation of the cumulative proportion data (incidence curves) by the product-limit-survival analysis yielded a P value of 0.029 (Mantel-Cox test), indicating a significant difference between MF-exposed and sham-exposed groups. Post-mortem examination showed that considerably more MF-exposed rats had developed mammary tumors than detected by palpation. Thus, 69 MF-exposed and 55 sham-exposed rats had developed macroscopically visible mammary rumors (Figure 1) . This difference was statistically significant (/> < 0.05). In the groups without DMBA treatment, no pathomorphologicai alterations were seen at autopsy.
Mean numbers of palpated tumors per tumor bearing rat of each DMB A-treated group are shown in Figure 2 . Rats of MFexposed and sham-exposed groups developed ~2.3 tumors on average (range 1-10) without significant differences between groups except at week 12. Determination of numbers of tumors per tumor bearing rat by examination of the mammary glands at autopsy did not indicate any significant difference (Figure 2 ). Total number of tumors was 139 in controls and 193 in MFexposed rats, respectively.
With respect to the size of tumors as estimated by palpation, the first tumors seemed to grow more rapidly in MF-exposed rats, which became significant at 7 weeks after the first DMBA application (Figure 3) . However, only six tumors in exposed and three tumors in sham-exposed rats were palpated at this time so that the difference was based on a very small number of tumors. At the subsequent weeks of cumulative increase in tumor incidence, median values obtained from both groups were similar without any indication of enhanced tumor growth in response to MF exposure (Figure 3 ). Corresponding to the data from palpation, data from measurement of tumor volume after autopsy did not indicate any significant difference between groups. The tumors of MF-exposed rats had an average volume of 518 (170-1602) mm 3 (median and interquartile range), compared with 656 (253-2310) mm 3 in the sham-exposed rats. These data are based on volume measurements of 178 tumors of MF-exposed and 134 tumors of sham-exposed rats, respect- ively. It should be noted that, particularly in MF-exposed rats, several large tumors could not be adequately measured and were thus not included in these data (see Materials and methods).
Effects of MF exposure on serum levels of melatonin
As shown in Figure 4 , no significant difference was seen in nocturnal melatonin levels in serum of DMBA-treated MFexposed and sham-exposed rats, although levels tended to be slightly lower in the MF-exposed animals.
Effects of MF exposure on T cell activation
Counting of viable lymphocytes before cells were cultured showed that DMBA-treated rats tended to have a lower number of splenic lymphocytes. Respective figures (means ± SE) were 324 ± 3lXl&/ml (sham-exposed without DMBA), 326 ± 32xlO 6 /ml (MF-exposed without DMBA), 232 ± 48XlO 6 /ml (sham-exposed with DMBA), and 201 ± 27X10 6 /ml (MFexposed with DMBA); ANOVA indicated that these mean data differed significantly (F = 3.175; P = 0.037). In all groups, the proliferation of splenic lymphocytes was stimulated by Con A as shown by the incorporation of [ 3 H]thymidine into DNA after culturing lymphocytes with the T cell selective mitogen Con A ( Figure 5) . However, the extent of stimulation differed significantly among groups. In rats without DMBA, MF exposure significantly suppressed T cell proliferation in response to Con A by >50% ( Figure 5) . A similar (-40%) reduction of T cell proliferation was seen in DMBA treated MF-exposed rats, but due to the large variation in the DMBAtreated group the difference was not significant. In shamexposed rats, the stimulation index of DMBA treated animals was not different from that of rats without DMBA ( Figure 5 ), but it should be noted that these data were determined 13 weeks after the first DMBA application.
Other findings
No behavioural differences were observed between exposed and sham-exposed animals during the 3-month period of exposure. Furthermore, the body weight gain did not differ significantly among the four groups of rats.
The weights of spleen and liver of DMBA-treated rats did not differ significantly between groups. Average spleen weight was 0.96 ± 0.14 g in MF-exposed and 0.81 ± 0.06 g in shamexposed rats, respectively. Liver weight was 10.3 ± 0.27 g in MF-exposed and 10.7 ± 0.18 g in sham-exposed rats, respectively.
Discussion
The present study indicates that long-term MF exposure of DMBA-treated female rats at a flux density of 50 uT significantly enhances mammary tumor development and growth. As shown by examination of animals at autopsy, incidence of macroscopically visible mammary tumors was 69.7% in MFexposed compared to 55.5% in sham-exposed rats. This 25.5% increase in tumor incidence of MF-exposed rats was statistically significant. Although this difference to sham-exposed controls appears to be not very impressive, it has to be seen in relation to previous studies of our group, using the same experimental protocol but different flux densities. As shown in Figure 6 , the autopsy data on macroscopically visible mammary tumors from the present experiment with 50 (J.T show a lower increase of tumor incidence than a previous experiment with 100 |iT (11, 12) , but a higher increase of tumor incidence compared to flux densities <50 |iT (8, 13) , suggesting that the effect of MF exposure on DMBA-induced mammary carcinogenesis depends on the flux density, i.e. is dose-dependent. Indeed, linear regression analysis of the data shown in Figure 6 for 13 weeks of exposure yielded a correlation coefficient of 0.9944, indicating a highly significant (P < 0.01) relationship Comparison of the present data on MF exposure of DMBAtreated rats at 50 uT with previous experiments using the same DMBA and exposure protocol but other flux densities. Two sets of data are shown. On the left side of the figure, data from palpation of mammary tumors at 8 weeks of exposure are illustrated, while the right part of the figure shows data from autopsy, i.e. incidence of macroscopically visible mammary tumors after 13 weeks of exposure. Data are shown as percent increase in tumor incidence above concurrent sham-exposed controls. The average control tumor incidence at 8 weeks was 15%, whereas control tumor incidence at 13 weeks was 51%. Data are based on a total of 333 DMBA-treated sham-exposed controls and 333 DMBA-trcated MF-exposed rats. Stars indicate a significant difference from concurrent sham-control (P at least < 0.05).
between flux density and increase of tumor incidence in this model. Interestingly, when incidence of palpable tumors after 8 weeks of exposure was compared between the four available experiments, again the effect of MF exposure on DMBAinduced mammary carcinogenesis appeared to be dose-dependent with significant increases in tumor incidence seen at 50 (iT and 100 (J.T, but not at lower flux densities ( Figure 6 ). Linear regression analysis of the tumor incidence/flux density data of the four experiments yielded a correlation coefficient of 0.9639, again indicating a significant (P < 0.05) correlation between flux density and effect. One may oppose that it is questionable to use linear regression analysis to study data consisting of only four points, and that the data from week 8 or week 13 fits to a linear relationship only by chance. However, apart from the type of relationship, the data shown in Figure 6 clearly suggest that there is a dose-response relationship.
The increase in tumor incidence after 8 weeks of exposure at either 50 or 100 (iT appeared to be much higher than the respective increase after 13 weeks of exposure (Figure 6 ), but it has to be noted that after 8 weeks the tumor incidence in sham controls is considerably lower and more variable than 3 months following the first DMBA application (Figure 1) . Nevertheless, the data may indicate that MF-effects in the DMBA model might be much more pronounced if lower doses of DMBA (i.e. doses associated with lower tumor incidence in controls) had been used. The possibility that a lower dose of DMBA, and lower tumor burden in controls greatly increase the power of the experiments to detect effects of MF exposure should be studied experimentally. On the other hand, there is increasing evidence from different co-carcinogenesis models with chemical initiation of tumors to suggest that MF does not promote cancers, but rather exerts a co-promoting effect which is not seen when low doses of DMBA are used (4) .
In a recent report on subgroups of rats co-exposed with the animals of the present study, we described evidence for enhanced mitotic activity of breast epithelial stem cells in response to 50-Hz MF exposure at 50 |TT (19). Interestingly, MF exposure led to a markedly enhanced activity of ODC, a key enzyme in cell proliferation, in mammary tissue but not in various other tissues examined in this respect, indicating that MF exposure does not increase cell proliferation in general but exhibits target tissue selectivity in this respect. It is well known that enhanced proliferation of breast epithelial stem cells increases the risk of breast cancer formation by carcinogens such as DMBA (24) . Thus, this effect of MF exposure could explain the enhanced susceptibility of MF-exposed rats to DMBA-induced mammary carcinogenesis observed in the present study. If so, one would expect that earlier exposure of rats, i.e. before the first DMBA application, will increase the ability to detect effects on DMBA-induced mammary carcinogenesis. Again, this possibility should be studied experimentally. Both, the increase in breast epithelial stem cell proliferation as indicated by ODC measurements (19) and the effect of MF exposure on DMBA induced mammary carcinogenesis could be explained by reduction in pineal melatonin synthesis in response to MF exposure. Because of the suppressive action of melatonin on endocrine glands, reduced melatonin would lead to an increase in estrogen and/or prolactin release that leads to an increased proliferation of breast epithelial stem cells at risk (17). As shown by suppression of melatonin levels by pinealectomy or constant light exposure, this results in increased DMBA-induced cancer development and growth in female rats (24) . Furthermore, because melatonin is an effective inhibitor of mammary cancer growth (24) , reduced melatonin would facilitate the growth of existing DMBA-induced mammary tumors. However, in contrast to previous studies (7, 8, 13) , we did not determine any significant reduction in nocturnal melatonin levels in the present study in female rats.
Kato et al. (7) were the first to demonstrate that exposure of rats at a 50-Hz MF significantly reduces nocturnal melatonin levels in pineal gland and plasma. Male rats were exposed continuously to a circularly polarized MF at 1, 5, 50, or 250 \iT for 6 weeks. When determined at time of nocturnal peak levels, i.e. 6 h after the onset of the dark phase, a significant decrease of melatonin was observed in all MF-exposed groups, but no statistical differences were found among the exposed groups (7) . Similarly, we observed significant decreases in nocturnal serum melatonin in female DMBA-treated rats after long-term MF exposure at either 0.3-1 ^T (8) or 10 ^T (13) without much difference in the extent of melatonin suppression between the two flux densities. In both the experiments of Kato et al. (7) and our recent experiments (8,13) the MF-induced reduction in plasma or serum melatonin ranged between ~20 and 30% compared to sham controls. Interestingly, decreases of similar magnitude were reported by Graham et al. (25) in male volunteers in response to a 60-Hz, 20 |iT MF. Such small effects may be difficult to reproduce, even in the same laboratory, particularly because of the relatively high interindividual variation in melatonin levels. For instance, Yellon (26) performed three subsequent studies in hamsters using short-term exposure to a 60-Hz, 100 u,T MF and found significant reduction in nocturnal melatonin levels in only two of these studies. Yellon (26) suggested that the time of the year, animal age, or the endogenous response 908 to MF exposure may be variables involved in this apparent inconsistency in MF-effects on melatonin levels. Another explanation for the lack of MF-induced melatonin suppression in the present study may be the duration of MF exposure. Most previous studies on MF-effects on melatonin levels used either short-term exposure or exposures up to 6 weeks, but it is possible that adaptation to MF-effects on the pineal gland develops during longer exposure periods such as used in the present study. Therefore, we plan to study the effect of MF on melatonin levels at various exposure periods, including periods which may be critical in the present observations on mammary carcinogenesis. Furthermore, in view of the fact that MF suppression of human melatonin in the study of Graham et al. (25) was most marked after the time of peak levels rather than at time of peak levels, the time course of nocturnal melatonin will be examined under MF exposure. Even in the absence of reduced levels of melatonin, it is important to note that data from Liburdy's group (26a) strongly indicate that MF exposure in the U.Trange inhibits melatonin's oncostatic effect on breast cancer growth by an interaction at the cellular level, which might be more critical than effects on melatonin synthesis. Furthermore, an action of MF exposure on melatonin synthesis or function is only one of the possible explanations for MF-effects on tumor growth (4).
Apart from melatonin, the immune system has been implicated in effects of MF exposure on tumor development and growth (4,14-17). However, only few studies with in vivo exposure of animals are available in this respect. McLean et al. (16) reported some experimental evidence that 60-Hz MF exposure of mice may effect tumor growth by suppressing an immune surveillance system (natural killer cell activity), which would otherwise prevent or retard tumor growth. A pivotal event in the generation of immune responses to most antigens, including tumor antigens, is the activation of T lymphocytes (27) , which appear to be important for antitumor activity and its immune regulation (28) . Previous studies with the DMBA model of breast cancer have shown that immune system depression, including reduced splenocyte proliferative response to the T-dependent mitogen Con A, facilitates the rate of tumor growth (29) . In the present study in rats, prolonged in vivo exposure of female rats to a 50-Hz MF markedly inhibited the Con Astimulated incorporation of thymidine into DNA or splenic lymphocytes of DMBA-naive rats, an effect previously reported for immunosuppressive agents such as cyclosporine A (23) and chemical carcinogens (29) . Since Con Ainduced stimulation of lymphocytes is thought to reflect the proliferative response of T lymphocytes to antigens, including tumor antigens (30) , the present finding of reduced proliferative capacity of T cells in MF exposed rats could be critically involved in the enhanced development of DMBAinduced mammary cancers observed in the present and previous studies (11, 12) . For further exploration of this possibility, it is necessary to determine which subpopulations of T cells are suppressed by MF exposure. One possible explanation for the suppressed T cell proliferative capacity observed in the present experiments is the recently reported in vivo effect of MF exposure on interleukin activity (31), because interleukins are essential factors in the activation of T cells (30) .
The present data suggest that immunoprotection may be compromised by MF exposure and that this effect may account for enhanced tumor growth in the DMBA model of breast cancer in rats. However, in mice retrovirusassociated breast cancers are promoted by immune mechanisms, and immunosuppression during the premalignant phase reduces the incidence of breast cancer in such animals (31a). Likewise, in a subset of women who develop breast cancer, there is immune promotion of cancer (31b). Thus, the present finding of MF-induced immunosuppression may have a different functional consequence for different types of breast cancer.
Furthermore, it should be noted that the present immunological observations from chronic in vivo MF exposure are apparently in contrast to some observations from short-term in vitro MF exposures which indicated an activation/ proliferation rather than suppression of lymphocytes (32) (33) (34) (35) . On the other hand, Conti et al. (36) (37) (38) reported that MF exposure of human peripheral lymphocytes stimulated with optimal concentrations of T cell selective mitogens such as Con A resulted in markedly lower [ 3 H]thymidine incorporation, indicating that T cells may be particularly responsive to suppression by MF. Studies are under way to determine the effect of different MF exposure periods on T and B lymphocyte activation. Interleukin levels will be measured in these studies. Furthermore, because calcium ions are involved in the control of lymphocyte proliferation, and calcium signalling processes are thought to be targets for MF-effects (15, 34) , single cell calcium imaging will be used to determine calcium concentrations in lymphocytes isolated from rats after in vivo MF exposure.
In conclusion, the present experiments provide further evidence that prolonged 50-Hz MF exposure in the (arrange facilitates DMBA-induced breast cancer development and growth. By comparison of the present data with results from other flux densities, it appears that long-term MF exposure of DMBA-treated female rats increases the growth of mammary tumors in a highly dose-related fashion, which is the first evidence of a clear relationship between enhanced tumor growth and flux density of MF exposure. Although the flux densities associated with significant effects under the conditions of the experimental model used are clearly above most human MF exposure levels (39) , the data can certainly not be used to calculate thresholds for risk assessment. First, as outlined above, by using a high DMBA dose and by waiting until 52 days of age to begin MF exposure we may have reduced the sensitivity of the model to detect MF-effects on mammary carcinogenesis. Second, the differences in MF-induced current are quite large between rodents and man because of size and geometry differences so that much lower flux densities than in rodents may affect biological functions in man if the interaction mechanism is based on induced currents (40) . Third, there are several epidemiological studies suggesting an association between increased breast cancer risk and MF exposure at flux densities occurring at occupational and residential exposures (41) (42) (43) (44) (45) (46) . In the end, it will be a combination of the results of epidemiologic studies, animal studies and mechanistic studies that will provide data for a sound scientific judgment on the potential adverse human health effect of exposure to MF associated with the generation, transport and use of electricity. The next necessary step in our experimental series will be to replicate the findings in the DMBA model in our and other laboratories.
